
Renewed Optimism for Indian Pharma in the US: Opportunities and Cautions
In recent times, there has been renewed optimism surrounding the US business of Indian pharmaceutical companies. Once hailed as a significant opportunity, the US market had become a burden for Indian firms in recent years due to severe price erosion and compliance issues. However, the situation has been improving, and two key factors have brightened
Read more



Most Commented